Trial Profile
Assessment of Viral-Specific Memory T Cell Responses and Infection Rates in HLA-Sensitized Kidney Transplant Patients Treated With Everolimus and Low-Dose Tacrolimus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Cytomegalovirus infections; Epstein-Barr virus infections; Polyomavirus infections; Renal transplant rejection
- Focus Therapeutic Use
- 19 Aug 2015 New trial record